Peter Laverman

6.4k total citations
123 papers, 5.2k citations indexed

About

Peter Laverman is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Surgery. According to data from OpenAlex, Peter Laverman has authored 123 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Radiology, Nuclear Medicine and Imaging, 40 papers in Oncology and 25 papers in Surgery. Recurrent topics in Peter Laverman's work include Radiopharmaceutical Chemistry and Applications (48 papers), Peptidase Inhibition and Analysis (27 papers) and Medical Imaging Techniques and Applications (24 papers). Peter Laverman is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (48 papers), Peptidase Inhibition and Analysis (27 papers) and Medical Imaging Techniques and Applications (24 papers). Peter Laverman collaborates with scholars based in Netherlands, United States and Germany. Peter Laverman's co-authors include Otto C. Boerman, Wim J.G. Oyen, Frans H.M. Corstens, Gert Storm, E.T.M. Dams, David M. Goldenberg, William J. McBride, Robert M. Sharkey, Gerben M. Franssen and J.W.M. van der Meer and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Advanced Drug Delivery Reviews.

In The Last Decade

Peter Laverman

123 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Laverman Netherlands 41 2.3k 1.6k 1.3k 1.1k 698 123 5.2k
Xiankai Sun United States 45 1.6k 0.7× 1.7k 1.1× 985 0.8× 979 0.9× 1.1k 1.6× 136 5.8k
Christopher P. Leamon United States 43 1.1k 0.5× 3.2k 2.0× 1.7k 1.4× 1.7k 1.6× 1.3k 1.8× 94 6.6k
Steve R. Roffler Taiwan 42 975 0.4× 3.4k 2.1× 1.3k 1.1× 1.1k 1.0× 905 1.3× 168 6.1k
Gary L. Griffiths United States 43 2.2k 1.0× 1.4k 0.9× 980 0.8× 375 0.3× 475 0.7× 116 4.6k
Wayne L. Monsky United States 27 739 0.3× 1.7k 1.1× 895 0.7× 1.4k 1.3× 1.6k 2.3× 84 5.2k
Raymond M. Reilly Canada 44 3.2k 1.4× 1.6k 1.0× 1.7k 1.3× 1.2k 1.1× 1.2k 1.7× 174 6.3k
Stephen J. Kennel United States 50 2.1k 0.9× 3.4k 2.2× 857 0.7× 637 0.6× 440 0.6× 203 6.8k
Zhaofei Liu China 40 1.8k 0.8× 1.6k 1.0× 1.4k 1.1× 603 0.6× 1.4k 2.0× 119 5.0k
William T. Phillips United States 37 925 0.4× 1.1k 0.7× 369 0.3× 1.2k 1.1× 941 1.3× 156 3.8k
Katherine A. Vallis United Kingdom 40 1.8k 0.8× 1.4k 0.9× 1.4k 1.1× 389 0.4× 607 0.9× 154 4.6k

Countries citing papers authored by Peter Laverman

Since Specialization
Citations

This map shows the geographic impact of Peter Laverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Laverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Laverman more than expected).

Fields of papers citing papers by Peter Laverman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Laverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Laverman. The network helps show where Peter Laverman may publish in the future.

Co-authorship network of co-authors of Peter Laverman

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Laverman. A scholar is included among the top collaborators of Peter Laverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Laverman. Peter Laverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ceglie, Irene Di, Arjen B. Blom, Desirée L. Bos, et al.. (2023). CD64 as novel molecular imaging marker for the characterization of synovitis in rheumatoid arthritis. Arthritis Research & Therapy. 25(1). 158–158. 5 indexed citations
2.
Derks, Yvonne H. W., Melline G.M. Schilham, Mark Rijpkema, et al.. (2023). Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand. European Journal of Nuclear Medicine and Molecular Imaging. 50(9). 2872–2884. 11 indexed citations
3.
Derks, Yvonne H. W., Mark Rijpkema, Annemarie Kip, et al.. (2021). Strain-Promoted Azide–Alkyne Cycloaddition-Based PSMA-Targeting Ligands for Multimodal Intraoperative Tumor Detection of Prostate Cancer. Bioconjugate Chemistry. 33(1). 194–205. 19 indexed citations
4.
Antunes, Inês F., et al.. (2020). New sensitive method for HEPES quantification in 68Ga-radiopharmaceuticals. European Journal of Nuclear Medicine and Molecular Imaging. 5(1). 3 indexed citations
5.
Franssen, Gerben M., et al.. (2015). A Fully Automated Procedure for the GMP-Synthesis of 68Ga-NODAGA-Exendin-4 Using a Cationic Purification Method. European Journal of Nuclear Medicine and Molecular Imaging. 42. 2 indexed citations
6.
Metselaar, Josbert M., Danny Gerrits, P.L. van Lent, et al.. (2015). [ 18 ]F FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis. Journal of Controlled Release. 209. 20–26. 21 indexed citations
7.
Laverman, Peter, Danny Gerrits, Gerben M. Franssen, et al.. (2015). Comparison of three remote radiolabelling methods for long-circulating liposomes. Journal of Controlled Release. 220(Pt A). 239–244. 23 indexed citations
8.
Corvo, M. Luísa, H. Susana Marinho, Paulo Marcelino, et al.. (2014). Superoxide Dismutase Enzymosomes: Carrier Capacity Optimization, in Vivo Behaviour and Therapeutic Activity. Pharmaceutical Research. 32(1). 91–102. 30 indexed citations
9.
Chatalic, Kristell L.S., Gerben M. Franssen, Wytske M. van Weerden, et al.. (2014). Preclinical Comparison of Al18F- and 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer. Journal of Nuclear Medicine. 55(12). 2050–2056. 44 indexed citations
10.
Stillebroer, Alexander B., Gerben M. Franssen, Peter F.A. Mulders, et al.. (2013). ImmunoPET Imaging of Renal Cell Carcinoma with 124 I- and 89 Zr-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice. Cancer Biotherapy and Radiopharmaceuticals. 28(7). 510–515. 42 indexed citations
11.
Laverman, Peter, et al.. (2013). Effects of attenuation map accuracy on attenuation-corrected micro-SPECT images. EJNMMI Research. 3(1). 7–7. 4 indexed citations
12.
Ventura, Manuela, Yi Sun, Peter Laverman, et al.. (2012). Dual Contrast Agent for Computed Tomography and Magnetic Resonance Hard Tissue Imaging. Tissue Engineering Part C Methods. 19(6). 405–416. 20 indexed citations
13.
Laverman, Peter, Christopher D'Souza, Annemarie Eek, et al.. (2011). Optimized labeling of NOTA-conjugated octreotide with F-18. Tumor Biology. 33(2). 427–434. 65 indexed citations
14.
Jong, Johan R. de, Frans van der Have, Brendan Vastenhouw, et al.. (2011). Quantitative multi-pinhole small-animal SPECT: uniform versus non-uniform Chang attenuation correction. Physics in Medicine and Biology. 56(18). N183–N193. 26 indexed citations
15.
Tacken, Paul J., Ben Joosten, Anita Reddy, et al.. (2008). No Advantage of Cell-Penetrating Peptides over Receptor-Specific Antibodies in Targeting Antigen to Human Dendritic Cells for Cross-Presentation. The Journal of Immunology. 180(11). 7687–7696. 34 indexed citations
16.
Rennen, Huub J J M, Peter Laverman, Julliëtte E M van Eerd, et al.. (2007). PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formation. Nuclear Medicine and Biology. 34(6). 691–695. 16 indexed citations
17.
Laverman, Peter, Otto C. Boerman, Frans H.M. Corstens, & Wim J.G. Oyen. (2002). Fluorinated amino acids for tumour imaging with positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 29(5). 681–690. 158 indexed citations
18.
Laverman, Peter. (2001). Recognition and clearance of methoxypoly(ethyleneglycol)2000-grafted liposomes by macrophages with enhanced phagocytic capacity Implications in experimental and clinical oncology. Biochimica et Biophysica Acta (BBA) - General Subjects. 1526(3). 227–229. 25 indexed citations
19.
Storm, G., Peter Laverman, E.T.M. Dams, et al.. (2000). Preclinical and Clinical Evidence for Efficient Opsonization of Poly(Ethyleneglycol)-Liposomes. Journal of Liposome Research. 10(4). 461–466. 1 indexed citations
20.
Dams, E.T.M., Wim J.G. Oyen, O.C. Boerman, et al.. (1999). Detection of infection and inflammation with technetium-99m-labeled PEG-liposomes. European Journal of Nuclear Medicine and Molecular Imaging. 26. 1014–1014. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026